| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.92 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,922,851 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,660,378 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
29 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bianco James A |
CEO |
• • – |
2012-03-21 |
4 |
AS |
$1.30 |
$99,005 |
D/D |
(76,041) |
6,065,623 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2012-03-21 |
4 |
D |
$1.31 |
$9,947 |
D/D |
(7,593) |
2,450,808 |
|
- |
|
| Philips Craig |
President |
• – – |
2012-03-21 |
4 |
D |
$1.31 |
$9,947 |
D/D |
(7,593) |
3,980,841 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2012-03-21 |
4 |
D |
$1.31 |
$9,947 |
D/D |
(7,593) |
1,964,346 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2012-02-24 |
4 |
AS |
$1.29 |
$12,850 |
D/D |
(10,000) |
6,141,664 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2012-01-27 |
4 |
AS |
$1.31 |
$13,050 |
D/D |
(10,000) |
6,151,664 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,639,414 |
2,458,401 |
|
- |
|
| Philips Craig |
President |
• – – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,423,906 |
3,988,434 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,039,843 |
6,161,664 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,211,953 |
1,971,939 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,639,414 |
2,497,966 |
|
- |
|
| Tuckson Reed Vaughn |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
516,360 |
724,985 |
|
- |
|
| Telling Fred |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
516,360 |
826,360 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
776,411 |
1,204,233 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
516,360 |
873,350 |
|
- |
|
| Love Richard L |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
516,360 |
933,004 |
|
- |
|
| Bauer John H |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
516,360 |
862,510 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(673,636) |
818,987 |
|
- |
|
| Philips Craig |
President |
• – – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(996,659) |
1,564,528 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,661,100) |
2,121,821 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(498,329) |
759,986 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(673,636) |
858,552 |
|
- |
|
| Telling Fred |
Director |
– • – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(166,109) |
310,000 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(249,759) |
427,822 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(166,109) |
356,990 |
|
- |
|
742 Records found
|
|
Page 15 of 30 |
|
|
